Hormonal Treatment of Fibrocystic Disease
暂无分享,去创建一个
[1] P. Bruzzi,et al. Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast , 1997, BMJ.
[2] L. Brinton,et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia , 1993, Cancer.
[3] I. Fentiman,et al. Recent developments in the study of benign breast disease. , 1993 .
[4] B. J. Harrison,et al. Plasma fatty acid profiles in benign breast disorders , 1992, The British journal of surgery.
[5] I. Forsyth,et al. The mammary gland. , 1991, Bailliere's clinical endocrinology and metabolism.
[6] J. Hoskinson,et al. AETIOLOGY AND TREATMENT , 1991 .
[7] I. Fentiman,et al. LHRH analogue for treatment of recurrent and refractory mastalgia. , 1990, Annals of the Royal College of Surgeons of England.
[8] R. Mansel,et al. European multicentre trial of bromocriptine in cyclical mastalgia , 1990, The Lancet.
[9] H. Leis. Management of nipple discharge , 1989, World Journal of Surgery.
[10] M. Baum. Benign breast disease: The cost of the service and the cost to the patient , 1989, World journal of surgery.
[11] R. Blamey,et al. Long-term follow up of patients treated with a single course of danazol for recurrent breast cysts. , 1989, British journal of clinical practice. Supplement.
[12] R. Mansel,et al. Management of breast pain and nodularity , 1989, World journal of surgery.
[13] B. J. Harrison,et al. Low-dose danazol for mastalgia. , 1989, British journal of clinical practice. Supplement.
[14] B. J. Harrison,et al. Non‐cyclical mastalgia: An improved classification and treatment , 1989, The British journal of surgery.
[15] F. Peters,et al. Hyperprolactinemia and nonpuerperal mastitis (duct ectasia). , 1989, JAMA.
[16] I. Fentiman,et al. Dosage and duration of tamoxifen treatment for mastalgia: A controlled trial , 1988, The British journal of surgery.
[17] T. Powles,et al. TAMOXIFEN AND BENIGN BREAST PROBLEMS , 1987, The Lancet.
[18] C. Brown,et al. Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease. , 1987, British medical journal.
[19] J. Russo,et al. Development of the Human Mammary Gland , 1987 .
[20] M. Williams,et al. A controlled trial of danazol in the treatment of multiple recurrent breast cysts , 1986, The British journal of clinical practice.
[21] R. Blamey,et al. A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain. , 1986, The British journal of clinical practice.
[22] A. Döberl,et al. Reduction of Cysts in Fibrocystic Breast Disease during and after Danazol Treatment , 1986 .
[23] I. Fentiman,et al. DOUBLE-BLIND CONTROLLED TRIAL OF TAMOXIFEN THERAPY FOR MASTALGIA , 1986, The Lancet.
[24] H. Vorherr. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. , 1986, American journal of obstetrics and gynecology.
[25] R. Mansel,et al. PREDICTION OF RESPONSE TO ENDOCRINE THERAPY IN PRONOUNCED CYCLICAL MASTALGIA USING DYNAMIC TESTS OF PROLACTIN RELEASE , 1985, Clinical endocrinology.
[26] R. Mansel,et al. CLINICAL EXPERIENCE OF DRUG TREATMENTS FOR MASTALGIA , 1985, The Lancet.
[27] L. Dennerstein,et al. Progesterone and the premenstrual syndrome: a double blind crossover trial. , 1985, British medical journal.
[28] M. Dowsett,et al. Endocrine effects of danazol in the treatment of endometriosis , 1984, British journal of obstetrics and gynaecology.
[29] R. Greenblatt,et al. Fibrocystic "disease" of the breast. , 1982, The New England journal of medicine.
[30] C. Schuerch,et al. A pathologic study of benign breast diseases in Tokyo and New York , 1982, Cancer.
[31] S. Love,et al. Fibrocystic Disease of the Breast — A Nondisease? , 1982 .
[32] A. C. Wentz. Adverse effects of danazol in pregnancy. , 1982, Annals of internal medicine.
[33] R. Sellwood,et al. Bromocriptine in severe cyclical breast pain , 1982, The British journal of surgery.
[34] R. Mansel,et al. CONTROLLED TRIAL OF THE ANTIGONADOTROPIN DANAZOL IN PAINFUL NODULAR BENIGN BREAST DISEASE , 1982, The Lancet.
[35] P. Ylöstalo,et al. Bromocriptine and Norethisterone in the Treatment of Premenstrual Syndrome , 1982, Obstetrics and gynecology.
[36] H. Bohnet,et al. Changes of prolactin secretion following long-term danazol application. , 1981, Fertility and sterility.
[37] K J Ryan,et al. Danazol: endocrine pharmacology and therapeutic applications. , 1981, American journal of obstetrics and gynecology.
[38] C. Bodian,et al. Breast Carcinoma: Risk and Detection , 1981 .
[39] J. Buster,et al. Bromocriptine in the Treatment of Premenstrual Tension Syndrome , 1980, Obstetrics and gynecology.
[40] R. Greenblatt,et al. The treatment of benign breast disease with danazol. , 1980, Fertility and sterility.
[41] K. Menon,et al. Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3',5' cyclic monophosphate formation. , 1980, American journal of obstetrics and gynecology.
[42] D. Calne,et al. Bromocriptine. A clinical and pharmacological review. , 1980 .
[43] B. Sherman,et al. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. , 1979, The Journal of clinical investigation.
[44] I. Ricciardi,et al. Tamoxifen-induced regression of benign breast lesions. , 1979, Obstetrics and gynecology.
[45] W. Dmowski,et al. Endocrine properties and clinical application of danazol. , 1979, Fertility and sterility.
[46] T. Mygind,et al. Treatment of mastalgia with bromocriptine: a double-blind cross-over study. , 1979, British medical journal.
[47] D. Graham,et al. Adult pre-sacral teratoma. , 1979, Postgraduate medical journal.
[48] Brooks Jd. Danazol treatment of benign breast disease: a survey of U.S.A. multi-centre studies. , 1979 .
[49] J. Day. Clinical trials in the premenstrual syndrome , 1979 .
[50] J. J. Graham,et al. Prolactin Suppression in the Treatment of Premenstrual Syndrome , 1978, The Medical journal of Australia.
[51] R. Mansel,et al. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease , 1978, The British journal of surgery.
[52] R. Mansel,et al. Mastalgia: psychoneurosis or organic disease? , 1978, British medical journal.
[53] F. Kuttenn,et al. Traitement des mastopathies bénignes par la progestérone et les progestatifs. Résultats en fonction du type de la mastopathie (à propos de 260 observations). , 1978 .
[54] B. Andersch,et al. Treatment of premenstrual tension syndrome with bromocriptine. , 1978, Acta endocrinologica. Supplementum.
[55] P. Franchimont,et al. The effect of danazol on anterior pituitary function. , 1977, Fertility and sterility.
[56] J. Larsen,et al. EFFECT OF BROMOCRIPTINE ON THE PREMENSTRUAL SYNDROME. A DOUBLE‐BLIND CLINICAL TRIAL , 1977, British journal of obstetrics and gynaecology.
[57] I. Mowszowicz,et al. Inadequate corpus luteal function in women with benign breast diseases. , 1977, The Journal of clinical endocrinology and metabolism.
[58] R. Greenblatt,et al. The use of an impeded androgen--danazol--in the management of benign breast disorders. , 1977, American journal of obstetrics and gynecology.
[59] D. Piers. THYROID CANCER AND THERAPY WITH 131I , 1976, The Lancet.
[60] T. Lind,et al. HOW DOES DANAZOL WORK? , 1976, The Lancet.
[61] L. J. Benedek-Jaszmann,et al. PREMENSTRUAL TENSION AND FUNCTIONAL INFERTILITY Aetiology and Treatment , 1976, The Lancet.
[62] B. Macmahon,et al. Oral contraceptives and reduced risk of benign breast diseases. , 1976, The New England journal of medicine.
[63] K. Wilson,et al. The effect of danazol in the treatment of chronic cystic mastitis. , 1976, Obstetrics and gynecology.
[64] Jacques Lb. Letter: Standardisation of heparin for clinical use. , 1975 .
[65] B. Ringelhann,et al. Letter: Pseudohyperkalaemia in acute myeloid leukaemia. , 1974, Lancet.
[66] C. A. Paulsen,et al. Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol). , 1971, The Journal of clinical endocrinology and metabolism.
[67] R. Greenblatt,et al. Clinical studies with an antigonadotropin-Danazol. , 1971, Fertility and sterility.